ARCHIVES

DCT Board Approves Contract Recompetitions Worth 44.8 Million In First Year Awards

This article is from The Cancer Letter archive.

Vol. 08 No. 43 | November 5, 1982

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Planning 50th Anniversary In 1987, Seeks Information On Alumni For Observance In May

January 24, 1986

Crout Resigns As Director Of FDA Drugs Bureau

July 11, 1980

Provenge Met Criteria For Approval, Sponsor Says

May 1, 2009

Guest Editorial: Andrew Vickers on PSA Skepticism, Rational and Irrational

October 10, 2014

NSABP Executive Committee Joins Fisher In Suit Against Pitt

August 5, 1994

FDA News: Zydelig approved in three B-cell blood cancers

August 1, 2014